Drug Policies Skyline during COVID-19 Pandemic

The COVID-19 pandemic has produced an extraordinary care setting where physicians played, and continue to play, a critical role in containing viral spread and treating affected patients. Frontline workers have been receiving day-to-day new information about therapeutic advances. The purpose of the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Vita, Serena, Forliano, Dora, De Luca, Aldo, Beccacece, Alessia, Marchioni, Luisa, Nicastri, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307413/
https://www.ncbi.nlm.nih.gov/pubmed/34300283
http://dx.doi.org/10.3390/jcm10143117
_version_ 1783728040612724736
author Vita, Serena
Forliano, Dora
De Luca, Aldo
Beccacece, Alessia
Marchioni, Luisa
Nicastri, Emanuele
author_facet Vita, Serena
Forliano, Dora
De Luca, Aldo
Beccacece, Alessia
Marchioni, Luisa
Nicastri, Emanuele
author_sort Vita, Serena
collection PubMed
description The COVID-19 pandemic has produced an extraordinary care setting where physicians played, and continue to play, a critical role in containing viral spread and treating affected patients. Frontline workers have been receiving day-to-day new information about therapeutic advances. The purpose of the study is to analyse COVID-19 drug consumption trends in both acute and intensive care settings comparing Defined Daily Doses and the release of scientific clinical data from January to December 2020.
format Online
Article
Text
id pubmed-8307413
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83074132021-07-25 Drug Policies Skyline during COVID-19 Pandemic Vita, Serena Forliano, Dora De Luca, Aldo Beccacece, Alessia Marchioni, Luisa Nicastri, Emanuele J Clin Med Brief Report The COVID-19 pandemic has produced an extraordinary care setting where physicians played, and continue to play, a critical role in containing viral spread and treating affected patients. Frontline workers have been receiving day-to-day new information about therapeutic advances. The purpose of the study is to analyse COVID-19 drug consumption trends in both acute and intensive care settings comparing Defined Daily Doses and the release of scientific clinical data from January to December 2020. MDPI 2021-07-15 /pmc/articles/PMC8307413/ /pubmed/34300283 http://dx.doi.org/10.3390/jcm10143117 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Vita, Serena
Forliano, Dora
De Luca, Aldo
Beccacece, Alessia
Marchioni, Luisa
Nicastri, Emanuele
Drug Policies Skyline during COVID-19 Pandemic
title Drug Policies Skyline during COVID-19 Pandemic
title_full Drug Policies Skyline during COVID-19 Pandemic
title_fullStr Drug Policies Skyline during COVID-19 Pandemic
title_full_unstemmed Drug Policies Skyline during COVID-19 Pandemic
title_short Drug Policies Skyline during COVID-19 Pandemic
title_sort drug policies skyline during covid-19 pandemic
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307413/
https://www.ncbi.nlm.nih.gov/pubmed/34300283
http://dx.doi.org/10.3390/jcm10143117
work_keys_str_mv AT vitaserena drugpoliciesskylineduringcovid19pandemic
AT forlianodora drugpoliciesskylineduringcovid19pandemic
AT delucaaldo drugpoliciesskylineduringcovid19pandemic
AT beccacecealessia drugpoliciesskylineduringcovid19pandemic
AT marchioniluisa drugpoliciesskylineduringcovid19pandemic
AT nicastriemanuele drugpoliciesskylineduringcovid19pandemic
AT drugpoliciesskylineduringcovid19pandemic

Ejemplares similares